The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol
2011/09/13 by S. Shorvon, M. Ferlisi, Monica Ferlisi · 27 citations
Medicine · Neuroscience · #Epilepsy research and treatment #Neuroscience and Neuropharmacology Research #Pharmacological Effects and Toxicity Studies
paper · pdf · doi:10.1093/brain/awr215
Abstract
Super-refractory status epilepticus is defined as status epilepticus that continues or recurs 24 h or more after the onset of anaesthetic therapy, including those cases where status epilepticus recurs on the reduction or withdrawal of anaesthesia. It is an uncommon but important clinical problem with high mortality and morbidity rates. This article reviews the treatment approaches. There are no controlled or randomized studies, and so therapy has to be based on clinical reports and opinion. The published world literature on the following treatments was critically evaluated: anaesthetic agents, anti-epileptic drugs, magnesium infusion, pyridoxine, steroids and immunotherapy, ketogenic diet, hypothermia, emergency resective neurosurgery and multiple subpial transection, transcranial magnetic stimulation, vagal nerve stimulation, deep brain stimulation, electroconvulsive therapy, drainage of the cerebrospinal fluid and other older drug therapies. The importance of treating the identifying cause is stressed. A protocol and flowchart for managing super-refractory status epilepticus is suggested. In view of the small number of published reports, there is an urgent need for the establishment of a database of outcomes of individual therapies.
Citations
Cited by
- Magnesium in Man: Implications for Health and Disease
- An extreme type of new onset refractory status epilepticus with stimulus‐induced seizures in pharmacological isoelectric states
- Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. [europepmc]
- Treatment of status epilepticus with ketamine, are we there yet? [europepmc]
- Transcranial magnetic stimulation for refractory focal status epilepticus in the intensive care unit. [europepmc]
- A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches. [europepmc]
- Pediatric super-refractory status epilepticus treated with allopregnanolone. [europepmc]
- Functional outcome of prolonged refractory status epilepticus. [europepmc]
- Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal. [europepmc]
- Pharmacotherapy for Status Epilepticus. [europepmc]
- Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. [europepmc]
- Claustrum damage and refractory status epilepticus following febrile illness. [europepmc]
- Management of Status Epilepticus in Children. [europepmc]
- Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01). [europepmc]
- Recent advances in epilepsy. [europepmc]
- New-Onset Refractory Status Epilepticus with Claustrum Damage: Definition of the Clinical and Neuroimaging Features. [europepmc]
- Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany. [europepmc]
- Treatment of Refractory and Super-refractory Status Epilepticus. [europepmc]
- Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain. [europepmc]
- HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window. [europepmc]
- Nonconvulsive seizures and nonconvulsive status epilepticus in the neuro ICU should or should not be treated aggressively: A debate. [europepmc]
- Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. [europepmc]
- New-onset super-refractory status epilepticus: A case series of 26 patients. [europepmc]
- Treatment of Super-Refractory Status Epilepticus: A Review. [europepmc]
- Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus. [europepmc]
- Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay. [europepmc]
- Status epilepticus in the ICU. [europepmc]
Related